Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Real-time transcriptomic profiling in distinct experimental conditions.

Tamer Butto | Stefan Pastore | Max Müller | Kaushik Viswanathan Iyer | Marko Jörg | Julia Brechtel | Stefan Mündnich | Anna Wierczeiko | Kristina Friedland | Mark Helm | Marie-Luise Winz | Susanne Gerber
eLife | 2026

Nanopore technology offers real-time sequencing opportunities, providing rapid access to sequenced data and allowing researchers to manage the sequencing process efficiently, resulting in cost-effective strategies. Here, we present focused case studies demonstrating the versatility of real-time transcriptomics analysis in rapid quality control for long-read RNA-seq. We illustrate its utility through four experimental setups: (1) transcriptome profiling of distinct human cellular populations, (2) identification of experimentally enriched transcripts, (3) transcriptional analysis of cells under heat shock conditions, and (4) identification of experimentally manipulated genes (knockout and overexpression) in several yeast strains. We show how to perform multiple layers of quality control as soon as sequencing has started, addressing both the quality of the experimental and sequencing traits. Real-time quality control measures assess sample/condition variability and determine the number of identified genes per sample/condition. Furthermore, real-time differential gene/transcript expression analysis can be conducted at various time points post-sequencing initiation (PSI), revealing dynamic changes in gene/transcript expression between two conditions. Using real-time analysis, which occurs in parallel to the sequencing run, we identified differentially expressed genes/transcripts as early as 1 hr PSI. These changes were consistently observed throughout the entire sequencing process. We discuss the new possibilities offered by real-time data analysis, which have the potential to serve as a valuable tool for rapid and cost-effective quality checks in specific experimental settings and can be potentially integrated into clinical applications in the future.

Pubmed ID: 42084597

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: Deutsche Forschungsgemeinschaft,
    Id: 439669440
  • Agency: Deutsche Forschungsgemeinschaft,
    Id: 255344185
  • Agency: Deutsche Forschungsgemeinschaft,
    Id: 464588647
  • Agency: Deutsche Forschungsgemeinschaft,
    Id: TRR319 RMaP TP B05
  • Agency: Deutsche Forschungsgemeinschaft,
    Id: TP A05/C01/C03
  • Agency: Deutsche Forschungsgemeinschaft,
    Id: TRR319 RMaP TP A07
  • Agency: Deutsche Forschungsgemeinschaft,
    Id: TRR319 RMaP TP C04

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HEK293 (cell line)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HeLa (cell line)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions